BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11059746)

  • 1. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies.
    Tsai MS; Hornby AE; Lakins J; Lupu R
    Cancer Res; 2000 Oct; 60(20):5603-7. PubMed ID: 11059746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.
    Vellon L; Menendez JA; Lupu R
    Oncogene; 2005 May; 24(23):3759-73. PubMed ID: 15782133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
    Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
    Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.
    Menéndez JA; Mehmi I; Griggs DW; Lupu R
    Endocr Relat Cancer; 2003 Jun; 10(2):141-52. PubMed ID: 12790776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyr61 promotes breast tumorigenesis and cancer progression.
    Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
    Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.
    Xie D; Miller CW; O'Kelly J; Nakachi K; Sakashita A; Said JW; Gornbein J; Koeffler HP
    J Biol Chem; 2001 Apr; 276(17):14187-94. PubMed ID: 11297518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
    Sampath D; Winneker RC; Zhang Z
    Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain.
    Grzeszkiewicz TM; Kirschling DJ; Chen N; Lau LF
    J Biol Chem; 2001 Jun; 276(24):21943-50. PubMed ID: 11287419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of heregulin in human coronary atherosclerotic lesions.
    Panutsopulos D; Arvanitis DL; Tsatsanis C; Papalambros E; Sigala F; Spandidos DA
    J Vasc Res; 2005; 42(6):463-74. PubMed ID: 16155362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.
    Lin MT; Chang CC; Chen ST; Chang HL; Su JL; Chau YP; Kuo ML
    J Biol Chem; 2004 Jun; 279(23):24015-23. PubMed ID: 15044484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
    Xie D; Nakachi K; Wang H; Elashoff R; Koeffler HP
    Cancer Res; 2001 Dec; 61(24):8917-23. PubMed ID: 11751417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans.
    Chen N; Chen CC; Lau LF
    J Biol Chem; 2000 Aug; 275(32):24953-61. PubMed ID: 10821835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.
    Hijazi MM; Thompson EW; Tang C; Coopman P; Torri JA; Yang D; Mueller SC; Lupu R
    Int J Oncol; 2000 Oct; 17(4):629-41. PubMed ID: 10995872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenic factor Cyr61 is induced by the progestin R5020 and is necessary for mammary adenocarcinoma cell growth.
    Sampath D; Winneker RC; Zhang Z
    Endocrine; 2002 Jul; 18(2):147-59. PubMed ID: 12374462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II.
    Hilfiker A; Hilfiker-Kleiner D; Fuchs M; Kaminski K; Lichtenberg A; Rothkötter HJ; Schieffer B; Drexler H
    Circulation; 2002 Jul; 106(2):254-60. PubMed ID: 12105167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway.
    Lin MT; Zuon CY; Chang CC; Chen ST; Chen CP; Lin BR; Wang MY; Jeng YM; Chang KJ; Lee PH; Chen WJ; Kuo ML
    Clin Cancer Res; 2005 Aug; 11(16):5809-20. PubMed ID: 16115920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1.
    Lin MT; Chang CC; Lin BR; Yang HY; Chu CY; Wu MH; Kuo ML
    J Biol Chem; 2007 Nov; 282(47):34594-604. PubMed ID: 17905740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells.
    Nguyen N; Kuliopulos A; Graham RA; Covic L
    Cancer Res; 2006 Mar; 66(5):2658-65. PubMed ID: 16510585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans.
    Grzeszkiewicz TM; Lindner V; Chen N; Lam SC; Lau LF
    Endocrinology; 2002 Apr; 143(4):1441-50. PubMed ID: 11897702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.